SPOTLIGHT: Group suspends Merck on ethics breach

The UK arm of Merck has been temporarily suspended from the British trade association for prescription drug producers for breaching the group's ethical standards. Merck was slapped for offering a program to help doctors with a blood pressure screening service provided they use Merck's blood pressure drug, Cozaar. A former salesman for the drug company brought the ethical breach to the group's attention. Merck said it regretted the situation. Report

Suggested Articles

Bristol Myers Squibb may have bounced Jounce from its roster of inherited partners, but it’s hanging onto Anokion, a Swiss autoimmune-focused biotech.

The priority review action date sets Bristol Myers up to win approval for the bluebird-partnered anti-BCMA CAR-T therapy in late March.

The unidentified biotechs are drawn from the portfolio of a €150 million life science-focused fund that Index Ventures set up.